Concord Biotech IPO aims to raise ₹1,551 crore with a price band of ₹705 to ₹741 per equity share. Subscription is open until August 8.
Concord Biotech IPO subscription open till August 8, aims to raise ₹1,551 crore
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.